CPT code 0072T identifies magnetic resonance imaging guided focused ultrasound (MRgFUS) for thermal ablation of noncancerous uterine leiomyomata with a treated volume of 200 cc or greater. This code captures a minimally invasive, image-guided alternative to surgical procedures for symptomatic uterine fibroids and is significant for payers and providers as adoption of MRgFUS may affect utilization patterns, imaging resource needs, and care pathways for fibroid management.

Key payers considered in national coverage discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a clinical and coding overview of the procedure, typical sites of service, and the context needed to interpret coverage and billing interactions. The publication presents benchmarks and policy-relevant points such as payer coverage trends, utilization considerations for an MR-based procedural service, and implications for ambulatory imaging and surgical centers that host MRI-guided interventions.

This summary equips clinical leaders, billing managers, and policy analysts with the essential framing of CPT code 0072T, including what the code represents, where the procedure is typically performed, and the topics addressed in the full report (coverage patterns, coding guidance, and clinical context). Data not available in the input is noted where specific payer policies or utilization statistics would otherwise be cited.